• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性皮肤弥漫性大B细胞淋巴瘤,腿型,以免疫性血小板减少症为首发主要表现

Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type with Immune Thrombocytopenia as the First Primary Presentation.

作者信息

Sun Yingying, Liu Chunyan, Wang Huaquan, Shao Zonghong

出版信息

Clin Lab. 2025 Aug 1;71(8). doi: 10.7754/Clin.Lab.2025.250156.

DOI:10.7754/Clin.Lab.2025.250156
PMID:40779461
Abstract

BACKGROUND

Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT) is a rare aggressive vari-ant of non-Hodgkin lymphoma (NHL). It is also clinically uncommon for NHL to primarily manifest as immune thrombocytopenia (ITP).

METHODS

We report a rare case of PCDLBCL-LT, which was misdiagnosed as primary refractory ITP. He achieved a complete remission of ITP by cyclophosphamide. Five months later, the patient developed recurrent erythematous plaques that disseminated to his entire body, accompanied by extracutaneous lesions.

RESULTS

Skin biopsy indicated PCDLBCL-LT. After one cycle of CHOP regimen, the patient's condition improved.

CONCLUSIONS

When encountering refractory ITP, it is important to identify potential underlying causes.

摘要

背景

原发性皮肤弥漫性大B细胞淋巴瘤,腿部型(PCDLBCL-LT)是一种罕见的侵袭性非霍奇金淋巴瘤(NHL)变体。NHL主要表现为免疫性血小板减少症(ITP)在临床上也不常见。

方法

我们报告了一例罕见的PCDLBCL-LT病例,该病例最初被误诊为原发性难治性ITP。他通过环磷酰胺治疗使ITP完全缓解。五个月后,患者出现复发性红斑斑块并扩散至全身,伴有皮肤外病变。

结果

皮肤活检显示为PCDLBCL-LT。经过一个周期的CHOP方案治疗后,患者病情有所改善。

结论

遇到难治性ITP时,识别潜在的潜在病因很重要。

相似文献

1
Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type with Immune Thrombocytopenia as the First Primary Presentation.原发性皮肤弥漫性大B细胞淋巴瘤,腿型,以免疫性血小板减少症为首发主要表现
Clin Lab. 2025 Aug 1;71(8). doi: 10.7754/Clin.Lab.2025.250156.
2
Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type.原发性皮肤弥漫性大 B 细胞淋巴瘤,腿型的结果。
Hematol Oncol. 2021 Dec;39(5):658-663. doi: 10.1002/hon.2919. Epub 2021 Aug 28.
3
Treating newly diagnosed Diffuse Large B-cell Lymphoma in the elderly patient with R-mini-CHOP: A single centre analytical retrospective observational study.用R-mini-CHOP方案治疗老年新诊断弥漫性大B细胞淋巴瘤:一项单中心分析性回顾性观察研究。
Med J Malaysia. 2025 May;80(3):307-312.
4
Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation.利妥昔单抗(美罗华)治疗侵袭性非霍奇金淋巴瘤:系统评价与经济学评估
Health Technol Assess. 2004 Sep;8(37):iii, ix-xi, 1-82. doi: 10.3310/hta8370.
5
Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - diagnostic and therapeutic challenges.原发性皮肤弥漫性大 B 细胞淋巴瘤,腿型,采用改良 R-CHOP 免疫化疗治疗 - 诊断和治疗挑战。
J Dtsch Dermatol Ges. 2011 Mar;9(3):204-11. doi: 10.1111/j.1610-0387.2010.07578.x. Epub 2010 Dec 2.
6
Primary cutaneous diffuse large B cell lymphoma, leg type.原发性皮肤弥漫性大B细胞淋巴瘤,腿部型
Indian J Dermatol Venereol Leprol. 2011 Mar-Apr;77(2):212-4. doi: 10.4103/0378-6323.77473.
7
Synchronous primary gastric diffuse large B-cell lymphoma and multiple lung primary adenocarcinoma with pulmonary cryptococosis: a case report and literature review.胃原发性弥漫大 B 细胞淋巴瘤与肺部多原发性腺癌伴肺部隐球菌病:一例病例报告并文献复习。
BMC Pulm Med. 2024 Oct 24;24(1):528. doi: 10.1186/s12890-024-03352-8.
8
Rituximab induced lung injury.利妥昔单抗诱发的肺损伤。
BMC Pulm Med. 2025 Jul 28;25(1):359. doi: 10.1186/s12890-025-03802-x.
9
[Prognostic factors in elderly patients with diffuse large B-cell lymphoma and their treatment results.].[老年弥漫性大B细胞淋巴瘤患者的预后因素及其治疗结果。]
Adv Gerontol. 2025;38(2):236-242.
10
[An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].[原发性皮肤弥漫性B细胞淋巴瘤,腿部型的一种非典型表现]
Ann Dermatol Venereol. 2011 Aug-Sep;138(8-9):601-4. doi: 10.1016/j.annder.2011.02.020. Epub 2011 Apr 23.